NuVasive Net Income | NUVA

Net profit is a financial indicator that reflects the remaining amount of money after deducting all expenses and taxes from the company’s total income over a certain period of time. It is one of the key indicators of a company’s financial stability and success.

Net profit is the portion of total profit remaining after taxes and depreciation have been deducted.^[1]

It is the result of a company’s operations and reflects its efficiency in managing resources, controlling expenses, and generating income. It includes all operating revenues and expenses, such as sales of goods or services, production costs, administrative expenses, taxes, and other financial metrics.

The calculation of net profit includes the deduction of all necessary expenses such as employee salaries, rent, utilities, taxes, and other mandatory payments. After all these expenses are deducted from the total income, the remaining amount is considered the company’s net profit.

Net profit is an important indicator of a company’s financial health, as it reflects its ability to generate earnings and manage its finances. High net profit indicates business success, competitiveness, and efficiency in resource utilization. It also allows a company to invest in its development, pay dividends to shareholders, or create reserve funds for unforeseen situations.

It serves as a basis for calculating other financial indicators, such as return on sales, return on assets, or return on equity. It is also used to assess the performance of management and make decisions regarding the future development of the company.

However, it should be noted that net profit can be affected by various factors, such as economic conditions, changes in legislation, market competition, and other external influences. Therefore, companies must be prepared for possible changes and take measures to ensure the stability of their financial results.

Annual Net Income NuVasive

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
40.4 M	-64.1 M	-37.2 M	65.2 M	12.5 M	81.6 M	37.2 M	66.3 M	-16.7 M	7.9 M	3.14 M	-69.8 M	78.3 M	5.81 M	-27.5 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
81.6 M	-69.8 M	12.2 M

Quarterly Net Income NuVasive

2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1	2010-Q3	2010-Q2
7.36 M	-1.01 M	-	-1.98 M	-893 K	19.2 M	-	-21.6 M	1.8 M	-7.51 M	-	5.87 M	-50 M	5.3 M	29.9 M	11 M	15 M	9.39 M	12.2 M	15.9 M	11.5 M	-27.1 M	23.5 M	33.6 M	12.7 M	12.8 M	6.38 M	3.93 M	30.2 M	-8.89 M	11.5 M	13 M	10.3 M	31.6 M	7.47 M	-1.83 M	-4.09 M	-18.3 M	6.01 M	7.51 M	-6.47 M	851 K	-2.75 M	2.35 M	2.86 M	673 K	-10 M	-67.6 M	5.38 M	2.36 M	8.54 M	6.72 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
33.6 M	-67.6 M	3.15 M

References

Bhamornsiri, S., & Wiggins, C. (2001). Comprehensive income disclosures. The CPA Journal, 71(10), 54.

Net Income of other stocks in the Medical devices industry

Issuer	Net Income	Price	% 24h	Market Cap	Country
Sientra SIEN	-22 M	-	-16.59 %	$ 10.3 M	USA
Silk Road Medical, Inc SILK	-55.7 M	-	-	$ 1.07 B	USA
Surgalign Holdings SRGA	-54.6 M	-	-32.98 %	$ 1.68 M	USA
ShockWave Medical SWAV	147 M	-	-	$ 12.3 B	USA
Titan Medical TMDI	-14.9 M	-	-26.32 %	$ 19.6 M	Canada
Natus Medical Incorporated NTUS	13.2 M	-	1.94 %	$ 1.05 B	USA
Cardiovascular Systems CSII	-36.9 M	-	0.15 %	$ 844 M	USA
Inari Medical NARI	-1.64 M	-	-	$ 4.23 B	USA
Invacare Corporation IVC	-20.6 M	-	-	$ 24.7 M	USA
Axonics Modulation Technologies AXNX	-6.09 M	-	-	$ 3.31 B	USA
ThermoGenesis Holdings THMO	-18.9 M	-	-25.84 %	$ 171 K	USA
Talis Biomedical Corporation TLIS	-62 M	-	3.55 %	$ 7.96 M	USA
Viveve Medical VIVE	-22 M	-	-15.35 %	$ 1.71 M	USA
ViewRay VRAY	-107 M	-	1.54 %	$ 468 M	USA
SmileDirectClub SDC	-86.4 M	-	-53.45 %	$ 9.71 M	USA
Acutus Medical AFIB	-9.55 M	-	-26.83 %	$ 2.62 M	USA
BIOLASE BIOL	-20.6 M	-	-13.19 %	$ 166 K	USA
Vapotherm VAPO	-58.2 M	-	6.72 %	$ 34 M	USA
SeaSpine Holdings Corporation SPNE	-54.3 M	-	0.28 %	$ 270 M	USA
Nevro Corp. NVRO	-113 M	-	-	$ 217 M	USA
Abiomed ABMD	137 M	-	-	$ 17.2 B	USA
Allied Healthcare Products AHPI	-1.94 M	-	3.58 %	$ 2.21 M	USA
Apollo Endosurgery APEN	-39.8 M	-	-	$ 475 M	USA
Avinger AVGR	-18.3 M	-	-20.74 %	$ 369 K	USA
Venus Concept VERO	-47 M	-	-	$ 726 K	USA
Zynex ZYXI	2.99 M	-	-	$ 21.1 M	USA
Conformis CFMS	-50.5 M	-	-	$ 16.4 M	USA
Eargo EAR	-157 M	-	-	$ 10.2 M	USA
Medigus Ltd. MDGS	4.05 M	-	10.28 %	$ 55.5 M	Israel
Cutera CUTR	-57.2 M	-	-10.19 %	$ 1.99 M	USA
GenMark Diagnostics, Inc. GNMK	-18.6 M	-	-	$ 1.77 B	USA
Obalon Therapeutics, Inc. OBLN	-12.3 M	-	-5.86 %	$ 30.6 M	USA
Hancock Jaffe Laboratories, Inc. HJLI	-9.14 K	-	-1.98 %	$ 98.3 M	USA
EDAP TMS S.A. EDAP	-19 M	-	-	$ 162 M	France
Soliton, Inc. SOLY	-14.5 M	-	-1.42 %	$ 435 M	USA
Itamar Medical Ltd. ITMR	-10.9 M	-	0.03 %	$ 1.58 B	Israel
Misonix, Inc. MSON	-17.4 M	-	-	$ 462 M	USA
Intersect ENT, Inc. XENT	-72.3 M	-	-	$ 955 M	USA
CryoLife, Inc. CRY	-16.7 M	-	-4.14 %	$ 702 M	USA
Avanos Medical AVNS	-72.9 M	$ 24.99	-	$ 1.16 B	USA
Aziyo Biologics AZYO	53.4 M	-	1.37 %	$ 20.5 M	USA
BioSig Technologies BSGM	-463 M	-	37.08 %	$ 85.7 M	USA
Dynatronics Corporation DYNT	-10.9 M	-	14.99 %	$ 929 K	USA
Second Sight Medical Products EYES	26.6 M	-	-0.97 %	$ 54.4 M	USA
FONAR Corporation FONR	8.33 M	-	-	$ 140 M	USA
GBS GBS	-12.4 M	-	-0.57 %	$ 7.12 M	USA
NanoVibronix NAOV	-18.2 M	-	-	$ 1.08 M	USA